1. A lentiviral vector‐based insertional mutagenesis screen identifies mechanisms of resistance to MAPK inhibitors in melanoma. (19th October 2018) Authors: Ranzani, Marco; Alifrangis, Constantine; Thompson, Nicola A.; Rust, Alistair G.; Allahyar, Amin; Iyer, Vivek; Price, Stacey; Ellis, Peter; Turner, Gemma; de Ridder, Jeroen; McDermott, Ultan; Adams, David J. Journal: Pigment cell & melanoma research Issue: Volume 32:Number 2(2019) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A patient‐centric pathway for testicular cancer – A multicentre study investigating the uptake of semen cryopreservation and impact on treatment. (28th February 2021) Authors: Scott, Charles; Omar, Kawa; Alnajjar, Hussain M.; Alifrangis, Constantine; Ahmed, Kamran; Muneer, Asif Journal: Andrology Issue: Volume 9:Number 3(2021) Page Start: 823 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti Ma2-associated myeloradiculopathy: expanding the phenotype of anti-Ma2 associated paraneoplastic syndromes. Issue 2 (4th January 2011) Authors: Murphy, Sinéad M; Khan, Usman; Alifrangis, Constantine; Hazell, Steven; Hrouda, David; Blake, Julian; Ball, Joanna; Gabriel, Carolyn; Markarian, Pierre; Rees, Jeremy; Karim, Abid; Seckl, Michael J; Lunn, Michael P; Reilly, Mary M Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 83:Issue 2(2012) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. BRAF/NRAS wild‐type melanoma, NF1 status and sensitivity to trametinib. (13th October 2014) Authors: Ranzani, Marco; Alifrangis, Constantine; Perna, Daniele; Dutton‐Regester, Ken; Pritchard, Antonia; Wong, Kim; Rashid, Mamunur; Robles‐Espinoza, Carla Daniela; Hayward, Nicholas K.; McDermott, Ultan; Garnett, Mathew; Adams, David J. Journal: Pigment cell & melanoma research Issue: Volume 28:Number 1(2015:Jan.) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BRAF/NRAS wild‐type melanoma, NF1 status and sensitivity to trametinib. (13th October 2014) Authors: Ranzani, Marco; Alifrangis, Constantine; Perna, Daniele; Dutton‐Regester, Ken; Pritchard, Antonia; Wong, Kim; Rashid, Mamunur; Robles‐Espinoza, Carla Daniela; Hayward, Nicholas K.; McDermott, Ultan; Garnett, Mathew; Adams, David J. Journal: Pigment cell & melanoma research Issue: Volume 28:Number 1(2015:Jan.) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Decoding germ cell tumours for clinicians. Issue 4 (July 2022) Authors: Haider, Aiman; Verrill, Clare; Alifrangis, Constantine; Berney, Daniel Maurice Journal: Current opinion in urology Issue: Volume 32:Issue 4(2022) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dose intense chemotherapy in the management of poor prognosis and relapsed testicular cancer: experiences and controversies. Issue 5 (4th May 2018) Authors: Ng, Kenrick; Duncan, Sarah; Shamash, Jonathan; Alifrangis, Constantine Journal: Expert review of anticancer therapy Issue: Volume 18:Issue 5(2018) Page Start: 431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dose‐dense chemotherapy for untreated poor‐prognosis and relapsed germ‐cell tumours: an 18‐year experience with GAMEC chemotherapy. (4th May 2020) Authors: Shamash, Jonathan; Mee, Matthew; Sarker, Shah‐Jalal; Wilson, Peter; Ansell, Wendy; Greenwood, Michelle; Berney, Dan; Alifrangis, Constantine Journal: BJU international Issue: Volume 125:Number 6(2020) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Genetics of gestational trophoblastic neoplasia: an update for the clinician. (December 2010) Authors: Alifrangis, Constantine; Seckl, Michael J Journal: Future oncology Issue: Volume 6:Number 12(2010) Page Start: 1915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours—A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleagues. (May 2018) Authors: Alifrangis, Constantine; Wilson, Peter; Shamash, Jonathan Journal: European journal of cancer Issue: Volume 95(2018) Page Start: 102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗